Found 223 matching trials
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus PHASE3 The purpose of this study is to evaluate the efficacy and safety of Piemont...
Show More Learn More & Join Trial
Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH PHASE2 A randomized, multi-center study evaluating MET409 (50 mg) alone or in comb...
Show More Location
Metacrine Investigative Site
Learn More & Join Trial
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients PHASE4 Chronic hepatitis B (CHB) affects 257million individuals worldwide. In 2017...
Show More Status
Active Not Recruiting
Location
The University of Hong Kong/Queen Mary Hospital
Learn More & Join Trial
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects PHASE4 The investigators hypothesise that empagliflozin 10mg daily will have haemo...
Show More Location
Queen Elizabeth University Hospital
Learn More & Join Trial
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin PHASE3 This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Show More Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy of SGLT2 Inhibitors in Adults With Sepsis NA Goal of this clinical trial is to examine the safety and efficacy of SGLT2 ...
Show More Location
4/F Main Clinical Block and Trauma Centre, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
Learn More & Join Trial
Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion NA Glucagon is a 29-amino acid peptide hormone of essential importance for glu...
Show More Location
Center for Clinical Metabolic Research
Learn More & Join Trial
Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes EARLY_PHASE1 This study aims to understand the heart and blood sugar health benefits of ...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart PHASE3 This study is open to adults with chronic heart failure (HF) who have a red...
Show More Location
Cure Clinical Research
Learn More & Join Trial
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study) PHASE4 To explore the beneficial effects of 'empagliflozin + ARB' in comparison wi...
Show More Location
Fukuoka University Chikushi Hospital
Learn More & Join Trial